Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide in Mantle Cell Lymphoma
NCT02489123Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Aug 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzalutamide in mantle cell lymphoma (MCL), sponsored by University of Washington. Started Aug 2015; status: terminated.
02
Drugs
enzalutamide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02489123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02489123.